United States ex rel. Austin & Montgomery v. Novartis

Frederick Mason Morgan Jr.

Case Conclusion Date:September 30, 2010

Practice Area:Fraud

Outcome:$410,000,000+ settlement

Description:Former Novartis sales representatives brought a qui tam case against Novartis for off-label marketing of anti-seizure drug Trileptal. After several years of investigation, Novartis agreed to pay more than $410 million to the U.S. and more than 20 states, and plead guilty to a federal criminal charge of illegal off-label marketing.